Early identification and appropriate engagement of patients experiencing first-episode symptoms of s...

The Food and Drug Administration (FDA) on Monday approved Abilify MyCite—aripiprazole tablets with a...

While most current antipsychotics are effective at reducing the positive symptoms of schizophrenia, ...

The development of new technologies to facilitate disease management is a burgeoning field, but expe...

First-episode psychosis patients who participated in a comprehensive, team-based treatment program a...